Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ACP Immunotherapy Workshop /
Predicting response to immunotherapy

13th Oct 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.10.17
Views: 1893

Prof Christian Ottensmeier - Southampton Royal Hospital, UK

Prof Ottensmeier speaks with ecancer at the ACP immunotherapy workshop about matching patients to treatments with predictive models of their likely response.

He describes assessments of changing cellular expression and broader microbiota to establish how likely treatments are to deliver tolerable, effective relief of cancer burden.

Prof Ottensmeier notes immune cell count and tumour penetration as predictive markers of immunotherapy response, with tumour resident memory T cells showing particular promise.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation